Capital Fund Management S.A. Celldex Therapeutics, Inc. Transaction History
Capital Fund Management S.A.
- $37.9 Billion
- Q4 2024
A detailed history of Capital Fund Management S.A. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 35,319 shares of CLDX stock, worth $730,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,319
Previous 35,867
1.53%
Holding current value
$730,043
Previous $1.22 Million
26.77%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$186 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$105 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$80.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$77.6 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $967M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...